Becton Dickinson & Co. FDA Record
- Latest inspection NAI · Apr 16, 2026
- 16 Class I recalls
- Last warning letter 2018
Becton Dickinson & Co. has 370 FDA recalls (16 Class I), 60 inspections, 356 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to Becton Dickinson & Co., the most recent on Jan 11, 2018. FDA has published 1 Form 483 for Becton Dickinson & Co..
- Latest recall
- Z-3275-2026 · Aug 20, 2026 · filed under Bard Peripheral Vascular
- Latest recall under this name
- Z-0139-2027 · Class II · Aug 13, 2026
- Latest inspection
- Apr 16, 2026 · NAI
- Latest 510(k)
- Oct 16, 2026
Newer recall under related name Bard Peripheral Vascular: Aug 20, 2026, Z-3275-2026.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 370 (16 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 356 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 60 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 2 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Becton Dickinson & Co.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 19 | 10 |
| 2025 | 1 | 0 | 0 | 11 | 0 |
| 2024 | 2 | 0 | 0 | 53 | 0 |
| 2023 | 4 | 0 | 0 | 16 | 0 |
| 2022 | 1 | 0 | 0 | 18 | 0 |
| 2021 | 1 | 0 | 0 | 5 | 0 |
| 2020 | 1 | 0 | 0 | 44 | 0 |
| 2019 | 2 | 0 | 0 | 67 | 2 |
| 2018 | 4 | 0 | 1 | 29 | 4 |
| 2017 | 6 | 0 | 0 | 16 | 0 |
Reviewing Becton Dickinson & Co. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Becton Dickinson & Co. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Becton Dickinson & Co. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jan 11, 2018 · Record page | |||
| May 11, 2009 · Record page |
Becton Dickinson & Co. Form 483s
| Date | Document | FEI |
|---|---|---|
| Sep 27, 2018 · Document on fda.gov | 483 | 2243072 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-0139-2027 | Class II | BD Phoenix Panel NMIC-312. Catalog Number: 449082. | Aug 13, 2026 |
| Z-0140-2027 | Class II | BD Phoenix Panel NMIC-306. Catalog Number: 449292. | Aug 13, 2026 |
| Z-3250-2026 | Class II | ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive… | Aug 11, 2026 |
| Z-2257-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2255-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2248-2026 | Class I | BD¿Spinal Tray with BD¿Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2249-2026 | Class I | BD¿Spinal Tray with BD¿Quincke Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2251-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2254-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2252-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 24 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2250-2026 | Class I | BD¿Spinal Tray with BD¿Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2253-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in., BD¿Quincke Needle 22 G x 3.5 in.; lidocaine… | Apr 27, 2026 |
| Z-2256-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL… | Apr 27, 2026 |
| Z-2203-2026 | Class II | Swan-Ganz Jr Catheter, Models: SGPT54, SGPT64P, SGPT755P | Apr 8, 2026 |
| Z-2202-2026 | Class II | Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/096F6P, C144F7… | Apr 8, 2026 |
| Z-2204-2026 | Class II | Swan-Ganz Pacing Catheter, Models: D200F7; | Apr 8, 2026 |
| Z-1982-2026 | Class II | BD GasPak EZ CO2 Pouch System. Catalog Number: 260684. for microbiologic use | Apr 7, 2026 |
| Z-1983-2026 | Class II | BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use | Apr 7, 2026 |
| Z-1496-2026 | Class II | 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units… | Jan 27, 2026 |
| Z-0484-2026 | Class II | BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100; | Oct 23, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 16, 2026 | San Diego, CA | Devices | No Action Indicated (NAI) | 3007886372 |
| Aug 1, 2025 | Sparks, MD | Devices | No Action Indicated (NAI) | 1119779 |
| May 21, 2024 | Sandy, UT | Devices | No Action Indicated (NAI) | 1710034 |
| May 2, 2024 | Drogheda, Ireland | Devices | Voluntary Action Indicated (VAI) | 3005698992 |
| Sep 15, 2023 | Canaan, CT | Devices | No Action Indicated (NAI) | 1213809 |
| Sep 15, 2023 | Mebane, NC | Devices | No Action Indicated (NAI) | 3008007472 |
| Mar 23, 2023 | Broken Bow, NE | Devices | No Action Indicated (NAI) | 1917413 |
| Jan 11, 2023 | San Diego, CA | Devices | No Action Indicated (NAI) | 3007886372 |
| Jun 8, 2022 | Hunt Valley, MD | Food/Cosmetics | No Action Indicated (NAI) | 1111096 |
| Jul 23, 2021 | Sparks, MD | Devices | Voluntary Action Indicated (VAI) | 1119779 |
| Mar 17, 2020 | Franklin Lakes, NJ | Devices | Voluntary Action Indicated (VAI) | 2243072 |
| Aug 7, 2019 | Durham, NC | Devices | No Action Indicated (NAI) | 3004173866 |
| Jul 24, 2019 | San Diego, CA | Devices | No Action Indicated (NAI) | 3007886372 |
| Dec 14, 2018 | Sandy, UT | Drugs | Voluntary Action Indicated (VAI) | 1710034 |
| Dec 7, 2018 | Fraga, Spain | Devices | Voluntary Action Indicated (VAI) | 3002682307 |
| Dec 5, 2018 | San Agustin Del Guadalix, Spain | Devices | Voluntary Action Indicated (VAI) | 3003152976 |
| Jan 29, 2018 | Sandy, UT | Devices | No Action Indicated (NAI) | 1710034 |
| Nov 15, 2017 | Drogheda, Ireland | Devices | No Action Indicated (NAI) | 3005698992 |
| Aug 2, 2017 | Canaan, CT | Devices | No Action Indicated (NAI) | 1213809 |
| May 18, 2017 | Broken Bow, NE | Devices | Voluntary Action Indicated (VAI) | 1917413 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 2 compliance actions under Becton Dickinson & Co.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3007886372 | San Diego, CA | 3 | Apr 16, 2026 |
| FEI 1119779 | Sparks, MD | 6 | Aug 1, 2025 |
| FEI 1710034 | Sandy, UT | 8 | May 21, 2024 |
| FEI 3005698992 | Drogheda, Ireland | 4 | May 2, 2024 |
| FEI 1213809 | Canaan, CT | 5 | Sep 15, 2023 |
| FEI 3008007472 | Mebane, NC | 6 | Sep 15, 2023 |
| FEI 1917413 | Broken Bow, NE | 6 | Mar 23, 2023 |
| FEI 1111096 | Hunt Valley, MD | 5 | Jun 8, 2022 |
| FEI 2243072 | Franklin Lakes, NJ | 3 | Mar 17, 2020 |
| FEI 3004173866 | Durham, NC | 2 | Aug 7, 2019 |
| FEI 3002682307 | Fraga, Spain | 2 | Dec 7, 2018 |
| FEI 3003152976 | San Agustin Del Guadalix, Spain | 3 | Dec 5, 2018 |
| FEI 1911916 | Columbus, NE | 5 | May 12, 2017 |
| FEI 3002809439 | Dublin, Ireland | 1 | Oct 21, 2015 |
| FEI 1000220943 | Carlsbad, CA | 1 | Aug 12, 2011 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K252344 | BD Vacutainer® Serum Blood Collection Tubes; BD Vacutainer® Rapid Serum Tubes (RST) | Oct 16, 2026 |
| K262163 | BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth | Sep 14, 2026 |
| K260128 | BD Preset and BD A-Line Arterial Blood Collection Syringes | Apr 15, 2026 |
| K252378 | BD® MiniDraw Capillary Blood Collection System with BD® MiniDraw SST Capillary Blood Collection… | Apr 10, 2026 |
| K252506 | BD Vacutainer® Safety-Lok Blood Collection Set; BD Vacutainer® Safety-Lok Blood Collection Set… | Apr 10, 2026 |
| K260184 | Onclarity Self-Collection Kit | Apr 2, 2026 |
| K252040 | BD Vacutainer® Plasma Separator Tubes (PST), BD Vacutainer® Sodium Heparin Blood Collection Tubes | Mar 13, 2026 |
| K253445 | BD Surgiphor 1000 mL Antimicrobial Irrigation System (910120) | Feb 20, 2026 |
| K250884 | 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe | Dec 2, 2025 |
| K250358 | BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and… | Oct 31, 2025 |
| K250059 | BD PhaSeal Optima Connecting Set (C83-O); BD PhaSeal Optima Spike Set (C180-O) | Sep 12, 2025 |
| K251713 | BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) | Aug 8, 2025 |
| K251350 | BD Plastipak Syringe | Jul 29, 2025 |
| K243207 | BD Vacutainer® Eclipse Blood Collection Needle | Jul 3, 2025 |
| K243062 | BD Intelliport System; BD Intelliport Reader (516230); BD Intelliport Sensor (516229); BD… | Jun 20, 2025 |
| K243872 | BD Veritor System for SARS-CoV-2 | Jun 16, 2025 |
| K250447 | BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL) | May 19, 2025 |
| K243649 | BD Vacutainer® Multiple Sample Luer Adapter | Mar 21, 2025 |
| K250344 | BD Phoenix Automated Microbiology System | Mar 6, 2025 |
| K243725 | BD Vaginal Panel | Dec 19, 2024 |
Becton Dickinson & Co. and the FDA: common questions
Has Becton Dickinson & Co. received an FDA warning letter?
Yes. FDA has issued 2 warning letters to Becton Dickinson & Co.. The most recent is dated Jan 11, 2018.
Has Becton Dickinson & Co. received an FDA Form 483?
FDA has published 1 Form 483 for Becton Dickinson & Co. in its reading room, the most recent dated Sep 27, 2018. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Becton Dickinson & Co.?
The most recent FDA inspection on file ended Apr 16, 2026 at San Diego, CA and was classified NAI. FDA has 60 inspections of Becton Dickinson & Co. on file.
Has Becton Dickinson & Co. had an FDA recall?
Yes. Becton Dickinson & Co. has 370 FDA recalls on record, 16 of them Class I, the most serious class. The most recent under this name started Aug 13, 2026. A newer recall, dated Aug 20, 2026, is filed under the related name Bard Peripheral Vascular.
Need more than this page shows? Ask about Becton Dickinson & Co. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.